Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: A randomized, double-blind, placebo-controlled, pilot clinical trial

Journal of Affective Disorders

Volumn 174, Issue , 2014, Pages 51-56

  Talaei, Ali ^a   Hassanpour Moghadam, Maryam ^b   Sajadi Tabassi, Sayyed Abolghasem ^c   Mohajeri, Seyed Ahmad ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Crocin; Herbal medicine; Major depressive disorder; Saffron (Crocus sativus L.)

Indexed keywords

CITALOPRAM; CROCIN; FLUOXETINE; PLACEBO; SERTRALINE; CAROTENOID; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FEMALE; GENERAL HEALTH QUESTIONNAIRE; HUMAN; IRAN; MAJOR DEPRESSION; MALE; MEDICATION COMPLIANCE; MENOMETRORRHAGIA; MENTAL PATIENT; METRORRHAGIA; MIDDLE AGED; MOOD DISORDER QUESTIONNAIRE; PATIENT COMPLIANCE; PILOT STUDY; PSYCHOPHARMACOTHERAPY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SIDE EFFECT; TABLET FORMULATION; TREATMENT DURATION; TREATMENT OUTCOME; CROCUS; DEPRESSIVE DISORDER, MAJOR; PHYTOTHERAPY; PROCEDURES; PSYCHOLOGICAL RATING SCALE;

ADULT; CAROTENOIDS; CITALOPRAM; CROCUS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; IRAN; MALE; MIDDLE AGED; PHYTOTHERAPY; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TREATMENT OUTCOME;

EID: 84918792426     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.11.035     Document Type: Article

References (54)

1. FI. Abdullaev Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.) Exp. Biol. Med. 227 2002 20 25
2. S. Adams, I. Penton-Voak, CJ. Harmer, EA. Holmes, and MR. Munafo Effects of emotion recognition training on mood among individuals with high levels of depressive symptoms: study protocol for a randomised controlled trial Trials 14 2013 161 168
3. M. Agha-Hosseini, L. Kashani, A. Aleyaseen, A. Ghoreishi, H. Rahmanpour, AR. Zarrinara, and S. Akhondzadeh Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo controlled trial BJOG 115 2008 515 519
4. M. Ak, B. Haciomeroglu, Y. Turan, N. Lapsekili, A. Doruk, and A. Bozkurt Temperament and character properties of male psoriasis patients J. Health Psychol. 17 2012 774 781
5. S. Akhondzadeh, N. Tahmacebi-Pour, AA. Noorbala, H. Amini, H. Fallah-Pour, AH. Jamshidi, and M. Khani Crocus sativus L. in the treatment of mild to moderate depression a double-blind, randomized and placebocontrolled trial Phytother. Res. 19 2005 148 151
6. AN. Assimopoulou, Z. Sinakos, and VP. Papageorgiou Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents Phytother. Res. 19 2005 997 1000
7. H. Ayatollahi, AO. Javan, M. Khajedaluee, M. Shahroodian, and H. Hosseinzadeh Effect of Crocus sativus L. (Saffron) on coagulation and anticoagulation systems in healthy volunteers Phytother. Res. 28 2014 539 543
8. M. Bauer, L. Dell'osso, S. Kasper, W. Pitchot, E. Dencker Vansvik, J. Kohler, L. Jørgensen, and SA. Montgomery Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder J. Affect. Disord. 151 2013 209 219
9. GA. Behr, JC. Moreira, and BN. Frey Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder Oxid. Med. Cell. Longev. 54 2012 421 429
10. F. Berger, A. Hensel, and K. Nieber Saffron extract and trans-crocetin inhibit glutamatergic synaptic transmission in rat cortical brain slices Neuroscience 180 2011 238 247
11. C. Blanco, JM. Rubio, M. Wall, R. Secades-Villa, K. Beesdo-Baum, and S. Wang The latent structure and comorbidity patterns of generalized anxiety disorder and major depressive disorder a national study J. Depress. Anxiety 31 2014 214 222
12. W. Bors, M. Saran, and C. Michel Radical intermediates involved in the bleaching of the carotenoid crocin. Hydroxyl radicals, superoxide anions and hydrated electrons Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 41 1982 493 501
13. LS. Caddell, and L. Clare Identity, mood, and quality of life in people with early-stage dementia Int. Psychogeriatr. 24 2012 1306 1315
14. E. Cascade, AH Kalali, and SH Kennedy Real-world data on ssri antidepressant side effects Psychiatry 6 2009 16 18
15. F. Cheung, Y. Feng, N. Wang, MF. Yuen, Y. Tong, and VT. Wong Effectiveness of Chinese herbal medicine in treating liver fibrosis: a systematic review and meta-analysis of randomized controlled trials Chin. Med. 7 2012 5 11
16. CP. Chung, D. Schmidt, CM. Stein, JD. Morrow, and RM. Salomon Increased oxidative stress in patients with depression and its relationship to treatment Psychiatry Res. 206 2013 213 216
17. E. Corruble, C. de Bodinat, C. Belaidi, and GM Goodwin Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial Int. J. Neuropsychopharmacol. 16 2013 2219 2234
18. JM. Ferguson SSRI antidepressant medications: adverse effects and tolerability Prim. Care Companion J. Clin. Psychiatry 3 2001 22 27
19. AM. Gadermann, CC. Engel, JA. Naifeh, MK. Nock, M. Petukhova, and PN. Santiago Prevalence of DSM-IV major depression among U.S. military personnel: meta-analysis and simulation Mil. Med. 177 2012 47 59
20. M. Gautam, Agrawal Mukta, P. Sharma, and AS. Gautam Role of antioxidants in generalised anxiety disorder and depression Indian J. Psychiatry 54 2012 244 247
21. W. Guo, F. Liu, J. Liu, L. Yu, Z. Zhang, and J. Zhang Is there a cerebellar compensatory effort in first-episode, treatment-naive major depressive disorder at rest Prog. Neuropsychopharmacol. Biol. Psychiatry 46 2010 13 18
22. F. Hadizadeh, SA. Mohajeri, and M. Seifi Extraction and purification of crocin from saffron stigmas employing a simple and efficient crystallization method Pak. J. Biol. Sci. 13 2010 691 698
23. DM. Hermann, G. Mies, and KA. Hossmann Biochemical changes and gene expression following traumatic brain injury: role of spreading depression Restor. Neurol. Neurosci. 14 1999 103 108
24. R. Heun, A. Ahokas, P. Boyer, N. Gimenez-Montesinos, F. Pontes-Soares, and V. Olivier The efficacy of agomelatine in elderly patients with recurrent major depressive disorder: a placebo-controlled study J. Clin. Psychiatry 74 2013 587 594
25. H. Hosseinzadeh, G. Karimi, and M. Niapoor Antidepressant effects of Crocus sativus stigma extracts and its constituents, crocin and safranal, in mice Acta Hortic. 650 2004 435 445
26. H. Hosseinzadeh, and V. Khosravan Anticonvulsant effects of aqueous and ethanolic extracts of Crocus sativus stigmas in mice Arch. Iran. Med. 5 2002 44 47
27. H. Hosseinzadeh, V. Motamedshariaty, and F. Hadizadeh Antidepressant effect of kaempferol, a constituent of saffron (Crocus sativus) petal, in mice and rats Pharmacologyonline 2 2007 367 370
28. H. Hosseinzadeh, HR. Sadeghnia, FA. Ghaeni, VS. Motamedshariaty, and SA. Mohajeri Effects of saffron (Crocus sativus L.) and its active constituent, crocin, on recognition and spatial memory after chronic cerebral hypoperfusion in rats Phytother. Res. 26 2012 381 386
29. H. Hosseinzadeh, and HM. Younesi Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice BMC Pharmacol. 15 2002 2 7
30. J. Jolly, JF. Aruffo, J. Wherry, and R. Livingston The utility of the beck anxiety inventory with inpatient adolescents J. Anxiety Disord. 7 1993 95 106
31. LL. Judd Mood disorders in the general population represent an important and worldwide public health problem Int. Clin. Psychopharmacol. 4 1995 5 10
32. J. Kashani, D. Sherman, D. Parker, and J. Reid Utility of the beck depression inventory with clinic-referred adolescents J. Am. Acad. Child Adolesc. Psychiatry 29 1990 278 282
33. L. Kashani, F. Raisi, S. Saroukhani, H. Sohrabi, A. Modabbernia, AA. Nasehi, A. Jamshidi, M. Ashrafi, P. Mansouri, P. Ghaeli, and S. Akhondzadeh Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study Hum. Psychopharmacol. 28 2013 54 60
34. RC. Kessler, WT. Chiu, O. Demler, KR. Merikangas, and EE. Walters Prevalence, severity, and comorbidity of twelve-month dsm-iv disorders in the national comorbidity survey replication Arch. Gen. Psychiatry 62 2005 617 627
35. KJ. Kircanski, J. Joormann, and IH. Gotlib Cognitive aspects of depression Wiley Interdiscip. Rev. Cogn. Sci. 3 2012 301 313
36. WR. Lindsay, and D. Skene The beck depression inventory ii and the beck anxiety inventory in people with intellectual disabilities: factor analyses and group data J. Appl. Res. Intellect. Disabil. 20 2007 401 408
37. PD. Loprinzi, C. Kane, and JF. Walker Association between physical activity and major depressive disorder among current or former smokers with pulmonary disease Prev. Med. 57 2013 545 549
38. BB. Martínez, and RP. Custódio Relationship between mental health and spiritual wellbeing among hemodialysis patients: a correlation study Sao Paulo Med. J. 132 2014 23 27
39. T. Masunaga, A. Kozlovsky, N. Takamura, and S. Yamashit Mental health status among younger generation around Chernobyl Arch. Med. Sci. 9 2013 1114 1116
40. TM. Michel, D. Pülschen, and J. Thome The role of oxidative stress in depressive disorders Curr. Pharm. 18 2012 5890 5899
41. AH. Mohamadpour, Z. Ayati, MR. Parizadeh, O. Rajbai, and H. Hosseinzadeh Safety evaluation of crocin (a constituent of saffron) tablets in healthy volunteers Iran. J. Basic Med. Sci. 16 2013 39 46
42. TK. Murphy, A. Segarra, EA. Storch, and WK. Goodman SSRI adverse events: how to monitor and manage Int. Rev. Psychiatry 20 2008 203 208
43. AA. Noorbala, S. Akhondzadeh, N. Tahmacebi-Pour, and AH. Jamshidi Hydroalcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial J. Ethnopharmacol. 97 2005 281 284
44. MA. Papandreou, CD. Kanakis, MG. Polissiou, S. Efthimiopoulos, P. Cordopatis, and M. Margarity Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents J. Agric. Food Chem. 54 2006 8762 8768
45. JL. RÍos, MC. Recio, RM. Giner, and S. Máňez An update review of saffron and its active constituents Phytother. Res. 10 1996 189 193
46. W. Rief, Y. Nestoriuc, A. von Lilienfeld-Toal, I. Dogan, F. Schreiber, and SG. Hofmann Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis Drug Saf. 32 2009 1041 1056
47. M. Saku The current clinical practice of herbal medicine in psychiatry in mainland China: a review of literature Jpn. J. Psychiatry Neurol. 45 1991 825 832
48. P. Sarkar, K. Chakraborty, A. Misra, R. Shukla, and SP. Swain Pattern of psychotropic prescription in a tertiary care center: a critical analysis Indian J. Pharmacol. 45 2013 270 273
49. J. Sarris, A. Panossian, I. Schweitzer, C. Stough, and A. Scholey Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence Eur. Neuropsychopharmacol. 21 2011 841 860
50. SK. Shemmassian, and SS. Lee Comparative validity of DSM-IV and alternative empirically derived approaches for the assessment of ADHD J. Atten. Disord. 8 2014 111 118
51. F. Uguz, M. Sahingoz, SA. Kose, O. Ozbebit, C. Sengul, Y. Selvi, CB. Sengul, MG. Ayhan, A. Dagistanli, and R. Askin Antidepressants and menstruation disorders in women: a cross-sectional study in three centers Gen. Hosp. Psychiatry 34 2012 529 533
52. Y. Zhang, Y. Shoyama, M. Sugiura, and H. Saito Effects of Crocus sativus L. on the ethanolinduced impairment of passive avoidanceperformances in mice Biol. Pharm. Bull. 17 1994 217 221
53. FL. Zhou, WG. Zhang, ZX. Su, X. Meng, and W. Tian Relationship between oxidative stress and depression in patients with acute leukemia Zhongguo Shi Yan Xue Ye Xue Za Zhi 14 2006 872 875
54. DF. Zullino, and Y. Khazaal Increased risk of gastrointestinal adverse effects under SSRI/NSAID combination may be due to pharmacokinetic interactions Br. J. Clin. Pharmacol. 59 2005 118 119